Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/05/019105
CTRI/2019/05/019105
Recruiting
未知

Integrating Pharmacogenomic and Population Pharmacokinetic Analysis for Precision Therapy of Isoniazid in TB Patients.

evin Thomas0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
evin Thomas
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
evin Thomas

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients diagnosed with TB.
  • •2\. Patients who are under minimum three days of Isoniazid therapy.
  • •3\. Age more than 18 years and less than 70 years.
  • •4\. Patients who are willing to give informed consent.

Exclusion Criteria

  • •1\. Vulnerable patients: Pregnant women and mentally challenged patients.
  • •2\. HIV positive patients.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Treatment with Tapentadol in Cancer PatientsHealth Condition 1: G893- Neoplasm related pain (acute) (chronic)
CTRI/2020/11/029206Manipal Academy of Higher Education
Not yet recruiting
Not Applicable
Impact of Genetic factors on Tacrolimus dosingHealth Condition 1: N990- Postprocedural (acute) (chronic) kidney failure
CTRI/2020/06/025498Manipal College of Pharmaceutical Sciences
Not yet recruiting
Not Applicable
Drug levels of Mycophenolic acid and the genetic mutations that affects these blood levels in patients with autoimmune diseases taking durg mycophenolate mofetil (MMF)Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified
CTRI/2023/03/050985Seth GS Medical College and KEM Hospital
Recruiting
Not Applicable
Study of factors (including genetic factors) influencing the levels of tacrolimus in blood before and after intake in renal transplant patientsHealth Condition 1: null- Renal transplant patients on tacrolimus
CTRI/2013/08/003871Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER30
Active, not recruiting
Not Applicable
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040
EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI